Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 1,4,5,6,7,8‑Hexahydropyrido[4,3‑d]pyrimidine inhibits HepG2 cell proliferation, migration and invasion, and induces apoptosis through the upregulation of miR‑26b‑5p by targeting CDK8. | Oncol Lett | 2023 | 37205919 | PubTator, text mining | PubMed |
| Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges. | Cells | 2023 | 37190100 | PubTator, text mining | PubMed |
| Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders. | Cells | 2023 | 37190068 | PubTator, text mining | PubMed |
| Changes in the mammary gland during aging and its links with breast diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37184281 | PubTator, text mining | PubMed |
| Absolute Stereochemistry and Cytotoxic Effects of Vismione E from Marine Sponge-Derived Fungus Aspergillus sp. 1901NT-1.2.2. | Int J Mol Sci | 2023 | 37175852 | PubTator, text mining | PubMed |
| m6 A-Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis. | Adv Sci (Weinh) | 2023 | 37171793 | PubTator, text mining | PubMed |
| The emerging theme of 3'UTR mRNA isoform regulation in reprogramming of cell metabolism. | Biochem Soc Trans | 2023 | 37171086 | PubTator, text mining | PubMed |
| Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation. | Sci Rep | 2023 | 37169829 | PubTator, text mining | PubMed |
| AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells. | J Immunother Cancer | 2023 | 37164450 | PubTator, text mining | PubMed |
| Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids. | Front Pharmacol | 2023 | 37153767 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Prevalence and clinical significance of co-existing mutations in MED12 and FH in uterine fibroids of Australian women. | Front Reprod Health | 2023 | 37113812 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals Cellular Heterogeneity in an Acral Amelanotic Melanoma After Immunotherapy Treatment. | Clin Cosmet Investig Dermatol | 2023 | 37077860 | PubTator, text mining | PubMed |
| Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study: A prospective diagnostic study. | Clin Epigenetics | 2023 | 37072801 | PubTator, text mining | PubMed |
| Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. | Mol Cancer Ther | 2023 | 37070927 | PubTator, text mining | PubMed |
| Distinct microRNA and protein profiles of extracellular vesicles secreted from myotubes from morbidly obese donors with type 2 diabetes in response to electrical pulse stimulation. | Front Physiol | 2023 | 37064893 | PubTator, text mining | PubMed |
| Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer. | Int J Biol Sci | 2023 | 37063429 | PubTator, text mining | PubMed |
| Transcriptional Reprogramming Regulates Tumor Cell Survival in Response to Ionizing Radiation: a Role of p53. | Bull Exp Biol Med | 2023 | 37060380 | PubTator, text mining | PubMed |
| Combining bioinformatics and machine learning to identify common mechanisms and biomarkers of chronic obstructive pulmonary disease and atrial fibrillation. | Front Cardiovasc Med | 2023 | 37057099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=14